95 related articles for article (PubMed ID: 10581175)
1. A novel human gene encoding HECT domain and RCC1-like repeats interacts with cyclins and is potentially regulated by the tumor suppressor proteins.
Mitsui K; Nakanishi M; Ohtsuka S; Norwood TH; Okabayashi K; Miyamoto C; Tanaka K; Yoshimura A; Ohtsubo M
Biochem Biophys Res Commun; 1999 Dec; 266(1):115-22. PubMed ID: 10581175
[TBL] [Abstract][Full Text] [Related]
2. The alternative reading frame tumor suppressor inhibits growth through p21-dependent and p21-independent pathways.
Modestou M; Puig-Antich V; Korgaonkar C; Eapen A; Quelle DE
Cancer Res; 2001 Apr; 61(7):3145-50. PubMed ID: 11306500
[TBL] [Abstract][Full Text] [Related]
3. P16Ink4a tumor suppressor function in lung cancer cells involves cyclin-dependent kinase 2 inhibition by Cip/Kip protein redistribution.
Grimison B; Langan TA; Sclafani RA
Cell Growth Differ; 2000 Oct; 11(10):507-15. PubMed ID: 11063124
[TBL] [Abstract][Full Text] [Related]
4. Acute renal failure during sepsis: potential role of cell cycle regulation.
Yang QH; Liu DW; Long Y; Liu HZ; Chai WZ; Wang XT
J Infect; 2009 Jun; 58(6):459-64. PubMed ID: 19428114
[TBL] [Abstract][Full Text] [Related]
5. Molecular cloning of a cyclin-like protein associated with cyclin-dependent kinase 3 (cdk 3) in vivo.
Matsuoka M; Matsuura Y; Semba K; Nishimoto I
Biochem Biophys Res Commun; 2000 Jul; 273(2):442-7. PubMed ID: 10873625
[TBL] [Abstract][Full Text] [Related]
6. Role of an ING1 growth regulator in transcriptional activation and targeted histone acetylation by the NuA4 complex.
Nourani A; Doyon Y; Utley RT; Allard S; Lane WS; Côté J
Mol Cell Biol; 2001 Nov; 21(22):7629-40. PubMed ID: 11604499
[TBL] [Abstract][Full Text] [Related]
7. Effect of tumor suppressors on cell cycle-regulatory genes: RB suppresses p34cdc2 expression and normal p53 suppresses cyclin A expression.
Yamamoto M; Yoshida M; Ono K; Fujita T; Ohtani-Fujita N; Sakai T; Nikaido T
Exp Cell Res; 1994 Jan; 210(1):94-101. PubMed ID: 8270002
[TBL] [Abstract][Full Text] [Related]
8. The Pezcoller lecture: cancer cell cycles revisited.
Sherr CJ
Cancer Res; 2000 Jul; 60(14):3689-95. PubMed ID: 10919634
[TBL] [Abstract][Full Text] [Related]
9. Herpes simplex virus type 1 infection imposes a G(1)/S block in asynchronously growing cells and prevents G(1) entry in quiescent cells.
Ehmann GL; McLean TI; Bachenheimer SL
Virology; 2000 Feb; 267(2):335-49. PubMed ID: 10662629
[TBL] [Abstract][Full Text] [Related]
10. Drosophila p53 is a structural and functional homolog of the tumor suppressor p53.
Ollmann M; Young LM; Di Como CJ; Karim F; Belvin M; Robertson S; Whittaker K; Demsky M; Fisher WW; Buchman A; Duyk G; Friedman L; Prives C; Kopczynski C
Cell; 2000 Mar; 101(1):91-101. PubMed ID: 10778859
[TBL] [Abstract][Full Text] [Related]
11. ING1 represses transcription by direct DNA binding and through effects on p53.
Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K
Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900
[TBL] [Abstract][Full Text] [Related]
12. Activation of an alfalfa cyclin-dependent kinase inhibitor by calmodulin-like domain protein kinase.
Pettkó-Szandtner A; Mészáros T; Horváth GV; Bakó L; Csordás-Tóth E; Blastyák A; Zhiponova M; Miskolczi P; Dudits D
Plant J; 2006 Apr; 46(1):111-23. PubMed ID: 16553899
[TBL] [Abstract][Full Text] [Related]
13. Integrin signaling at the M/G1 transition induces expression of cyclin E.
Hulleman E; Bijvelt JJ; Verkleij AJ; Verrips CT; Boonstra J
Exp Cell Res; 1999 Dec; 253(2):422-31. PubMed ID: 10585265
[TBL] [Abstract][Full Text] [Related]
14. p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements.
Campomenosi P; Monti P; Aprile A; Abbondandolo A; Frebourg T; Gold B; Crook T; Inga A; Resnick MA; Iggo R; Fronza G
Oncogene; 2001 Jun; 20(27):3573-9. PubMed ID: 11429705
[TBL] [Abstract][Full Text] [Related]
15. Regulation of cyclin-dependent kinase activity during mitotic exit and maintenance of genome stability by p21, p27, and p107.
Chibazakura T; McGrew SG; Cooper JA; Yoshikawa H; Roberts JM
Proc Natl Acad Sci U S A; 2004 Mar; 101(13):4465-70. PubMed ID: 15070741
[TBL] [Abstract][Full Text] [Related]
16. Tumor-suppressor effect of interferon regulatory factor-1 in human hepatocellular carcinoma.
Moriyama Y; Nishiguchi S; Tamori A; Koh N; Yano Y; Kubo S; Hirohashi K; Otani S
Clin Cancer Res; 2001 May; 7(5):1293-8. PubMed ID: 11350897
[TBL] [Abstract][Full Text] [Related]
17. Structure, expression, and chromosomal localization of human GAK.
Kimura SH; Tsuruga H; Yabuta N; Endo Y; Nojima H
Genomics; 1997 Sep; 44(2):179-87. PubMed ID: 9299234
[TBL] [Abstract][Full Text] [Related]
18. PACT: cloning and characterization of a cellular p53 binding protein that interacts with Rb.
Simons A; Melamed-Bessudo C; Wolkowicz R; Sperling J; Sperling R; Eisenbach L; Rotter V
Oncogene; 1997 Jan; 14(2):145-55. PubMed ID: 9010216
[TBL] [Abstract][Full Text] [Related]
19. Identification of p53 target genes through immune selection of genomic DNA: the cyclin G gene contains two distinct p53 binding sites.
Zauberman A; Lupo A; Oren M
Oncogene; 1995 Jun; 10(12):2361-6. PubMed ID: 7784084
[TBL] [Abstract][Full Text] [Related]
20. The nuclear oncoproteins: RB and p53.
Cowell JK
Semin Cancer Biol; 1990 Dec; 1(6):437-46. PubMed ID: 2151736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
